3 results
Approved WMOCompleted
Primary* To evaluate the effect of EDP1066 in multiple formulations on the systemic immune system.Secondary* To evaluate the safety and tolerability of EDP1066 in multiple formulations.
Approved WMORecruiting
The main objective is to study the efficacy of treatment with RTX in patients with relapsing PMR compared to placebo.
Approved WMORecruiting
The main objective is to study the efficacy of treatment with RTX in patients with newly diagnosed PMR compared to placebo.